SmartMeds+ Pharmacogenomics (PGx)

PGx testing provides insight into how patients may respond to certain medications based on DNA variants that affect pharmacokinetics and pharmacodynamics.

PGx testing equips physicians with a tool to enhance effective treatment decisions, potentially minimize the risk of adverse drug reactions, maximize efficacy, and reduce “trial and error” dosing and drug selection.

Our SmartMeds+ Pharmacogenomics test is fully aligned with FDA, CPIC, PharmGKB, AMP, and ACMG giving physicians insight into clinically actionable interactions including Phenoconversion.

We offer a comprehensive PGx panel with over 67 genes and 664 variants covering 294 medications across 22 therapeutic areas:

Anesthesiology

Cardiology

Dental

Dermatology

Endocrinology

Gastroenterology

Gynecology

Hematology

Immunology

Infectious Diseases

Neurology

Oncology

Ophthalmology

Othorhinolaryngology

Pain Management

Psychiatry

Respiratory

Rheumatology

Smoking Cessation

Supplements

Toxicology

Urology

Start personalized medicine today for better health tomorrow!

Need Help?

Visit the Innovative Gx Help Center

Get Help